130 related articles for article (PubMed ID: 7552140)
1. DNA-based presymptomatic diagnosis for the von Hippel-Lindau disease by linkage analysis.
Olschwang S; Boisson C; Richard S; Resche F; Thomas G
Eur J Hum Genet; 1995; 3(2):108-15. PubMed ID: 7552140
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
[TBL] [Abstract][Full Text] [Related]
3. Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers.
Maher ER; Bentley E; Payne SJ; Latif F; Richards FM; Chiano M; Hosoe S; Yates JR; Linehan M; Barton DE
J Med Genet; 1992 Dec; 29(12):902-5. PubMed ID: 1362224
[TBL] [Abstract][Full Text] [Related]
4. Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus.
Crossey PA; Maher ER; Jones MH; Richards FM; Latif F; Phipps ME; Lush M; Foster K; Tory K; Green JS
Hum Mol Genet; 1993 Mar; 2(3):279-82. PubMed ID: 8499917
[TBL] [Abstract][Full Text] [Related]
5. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.
Seizinger BR; Smith DI; Filling-Katz MR; Neumann H; Green JS; Choyke PL; Anderson KM; Freiman RN; Klauck SM; Whaley J
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2864-8. PubMed ID: 2011596
[TBL] [Abstract][Full Text] [Related]
6. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
[TBL] [Abstract][Full Text] [Related]
7. Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene.
Richards FM; Maher ER; Latif F; Phipps ME; Tory K; Lush M; Crossey PA; Oostra B; Enblad P; Gustavson KH
J Med Genet; 1993 Feb; 30(2):104-7. PubMed ID: 8445612
[TBL] [Abstract][Full Text] [Related]
8. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
9. Genetic mapping of dinucleotide repeat polymorphisms and von Hippel-Lindau disease on chromosome 3p25-26.
Pericak-Vance MA; Nunes KJ; Whisenant E; Loeb DB; Small KW; Stajich JM; Rimmler JB; Yamaoka LH; Smith DI; Drabkin HA
J Med Genet; 1993 Jun; 30(6):487-91. PubMed ID: 8100855
[TBL] [Abstract][Full Text] [Related]
10. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
Montera M; Bellone E; Ajmar F; Mandich P
Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
[No Abstract] [Full Text] [Related]
11. Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435.
Li H; Schmidt L; Duh FM; Wei MH; Latif F; Stackhouse T; Lerman MI; Zbar B; Tory K
Hum Mol Genet; 1993 Aug; 2(8):1326. PubMed ID: 8401520
[No Abstract] [Full Text] [Related]
12. [Von Hippel-Lindau disease].
Shuin T; Ashida S; Yao M; Kanno H
Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
[TBL] [Abstract][Full Text] [Related]
13. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis.
Maher ER; Bentley E; Yates JR; Latif F; Lerman M; Zbar B; Affara NA; Ferguson-Smith MA
Genomics; 1991 Aug; 10(4):957-60. PubMed ID: 1680799
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
[TBL] [Abstract][Full Text] [Related]
17. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
[TBL] [Abstract][Full Text] [Related]
18. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
Humphrey JS; Klausner RD; Linehan WM
Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471
[No Abstract] [Full Text] [Related]
19. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
20. Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.
Richards FM; Schofield PN; Fleming S; Maher ER
Hum Mol Genet; 1996 May; 5(5):639-44. PubMed ID: 8733131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
